psoriasis

J&J may be late to the psoriasis drug market party, but it’s planning to make a splash with guselkumab
Endpoints
Fri, 03/3/17 - 09:36 am
JNJ
psoriasis
guselkumab
Purdue Pharma Puts Skin In The Game With Psoriasis Deal
Seeking Alpha
Thu, 12/15/16 - 10:09 am
Purdue Pharma
psoriasis
AST-005
antisense
Exicure
Are DTC ads tipping the balance in psoriasis battle between Lilly’s Taltz and Novartis’ Cosentyx?
Fierce Pharma
Mon, 12/5/16 - 10:10 am
DTC advertising
psoriasis
Eli Lilly
Novartis
Taltz
Cosentyx
FDA OKs Expanded Use of Amgen's Enbrel
Investopedia
Thu, 11/10/16 - 10:18 am
FDA
Amgen
Enbrel
pediatrics
psoriasis
Eli Lilly’s new psoriasis treatment Taltz launches first ads, chasing Novartis’ Cosentyx lead
Fierce Pharma
Wed, 10/12/16 - 11:33 am
Eli Lilly
psoriasis
Novartis
Cosentyx
Taltz
drug ads
This Looks to Be Johnson & Johnson's Next Blockbuster Drug
Motley Fool
Wed, 10/5/16 - 09:40 am
JNJ
psoriasis
guselkumab
J&J psoriasis drug tops placebo, Humira in late stage study
Yahoo/Reuters
Mon, 10/3/16 - 09:42 pm
JNJ
psoriasis
Humira
AbbVie
guselkumab
Celgene's Otezla Is A Big Hit
Motley Fool
Thu, 07/28/16 - 08:49 pm
Celgene
Otezla
psoriasis
Valeant gets FDA panel recommendation for psoriasis drug
Marketwatch
Tue, 07/19/16 - 10:15 pm
Valeant Pharmaceutcals
FDA
advisory panels
psoriasis
brodalumab
FDA review details suicides, cardio risks linked to Valeant’s $100M drug brodalumab
Endpoints
Fri, 07/15/16 - 10:27 am
FDA
Valeant Pharmaceuticals
suicide
brodalumab
psoriasis
Valeant - Baby Steps Back To Prosperity
Seeking Alpha
Thu, 07/7/16 - 09:21 am
Valeant Pharmaceuticals
brodalumab
psoriasis
AstraZeneca Transfers Valeant's European Rights To Troubled Drug
Investors.com
Fri, 07/1/16 - 10:27 am
AstraZeneca
Valeant Pharmaceuticals
brodalumab
psoriasis
2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful
TheStreet.com
Tue, 04/5/16 - 10:06 pm
Regeneron
dupilumab
Anacor
Crisaborole Topical Ointment
psoriasis
eczema
FDA approves Eli Lilly drug for psoriasis
Yahoo/Reuters
Wed, 03/23/16 - 09:43 am
FDA
Eli Lilly
psoriasis
ixekizumab
J&J psoriasis drug Stelara tames Crohn's disease in second trial
Yahoo/Reuters
Fri, 03/18/16 - 10:41 am
JNJ
psoriasis
Stelara
Crohn's Disease
Novartis' Cosentyx proves superior to Janssen's Stelara in head-to-head comparison
BioPharma Dive
Mon, 03/7/16 - 10:00 pm
Novartis
Cosentyx
Janssen
Stelara
psoriasis
AbbVie to Pay $595 Million for Boehringer Immunology Treatments
Bloomberg
Mon, 03/7/16 - 09:33 am
AbbVie
Boehringer Ingelheim
M&A
psoriasis
Crohn’s disease
asthma
Vitae tanks after cutting its psoriasis trial short, stoking safety concerns
Fierce Biotech
Sat, 03/5/16 - 10:00 am
Vitae
clinical trials
psoriasis
VTP-43742
Merck forges ahead with phase 3 trial of Humira biosimilar
BioPharma Dive
Fri, 03/4/16 - 02:00 pm
Merck
Humira
biosimilar
MSB11022
AbbVie
psoriasis
Novartis' psoriasis mega-blockbuster hopeful Cosentyx nabs 2 new indications
BioPharma Dive
Tue, 01/19/16 - 10:41 am
Novartis
Cosentyx
psoriasis
psoriatic arthritis
ankylosing spondylitis

Pages